Biosenta Inc.
ZRO
CNSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -33.33% | 100.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -33.33% | 100.21% | |||
| Cost of Revenue | 0.00% | -50.00% | |||
| Gross Profit | -50.00% | 100.14% | |||
| SG&A Expenses | 28.05% | -12.28% | |||
| Depreciation & Amortization | -20.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.01% | -13.17% | |||
| Operating Income | -29.18% | 48.85% | |||
| Income Before Tax | -12.87% | 19.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.87% | 19.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.87% | 19.84% | |||
| EBIT | -29.18% | 48.85% | |||
| EBITDA | -29.19% | 48.89% | |||
| EPS Basic | -11.63% | 21.34% | |||
| Normalized Basic EPS | -11.11% | 21.36% | |||
| EPS Diluted | -11.63% | 21.34% | |||
| Normalized Diluted EPS | -11.11% | 21.36% | |||
| Average Basic Shares Outstanding | 1.51% | 1.77% | |||
| Average Diluted Shares Outstanding | 1.51% | 1.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||